Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > PHIZER just bought Trillium ---for--
View:
Post by Impalaman on Aug 23, 2021 8:24am

PHIZER just bought Trillium ---for--

about 3. billion CAD----now it's our turn.
Comment by Oilminerdeluxe on Aug 23, 2021 9:06am
I have a hard time seeing someone buying a 43 M market cap stock for 3 B, but I will niot complain if it happens. Right now, I yearn for signs of life. That newsletter better have some good stuff in it and not be a cut and paste thing. 
Comment by HomerAndCompany on Aug 23, 2021 9:09am
$18.50/share, closing price was $6.09, so >200% premium. Aug 23 (Reuters) - Trillium Therapeutics Inc: * PFIZER TO ACQUIRE TRILLIUM THERAPEUTICS INC. * TRILLIUM THERAPEUTICS INC - DEAL FOR IMPLIED EQUITY VALUE OF $2.26 BILLION * TRILLIUM THERAPEUTICS INC - DEAL FOR $18.50 PER SHARE, IN CASH * TRILLIUM THERAPEUTICS INC - PROPOSED DEAL OF TRILLIUM IS TO BE COMPLETED BY WAY OF A ...more  
Comment by gojotv! on Aug 23, 2021 3:10pm
That's pretty impressive, since Trillium doesn't even have a working cure for cancer. This supports my argument that Theralase shouldn't be sold cheap. We have maybe the only effective approach to fight glioblastoma, an irregular-cell-shaped cancer that is impossible to remove surgically and which is proliferating with our modern cellphone use. (Gordon Downie and Neil Peart both ...more  
Comment by 99942Apophis on Aug 23, 2021 4:33pm
Quite correct gojotv, if this was a one trick pony sure 3B buyout would be adequate. When we're looking at Bladder, lung, brain and an all virus & pathogen destroyer then yes you are in the ballpark at 100 bucks a share! We just need irrefutable proof from this trial that it does what we believe. 
Comment by Pandora on Aug 23, 2021 10:35pm
And what does a 200% premium to 20.5 cents give us??
Comment by enriquesuave on Aug 23, 2021 11:52pm
Trillium partnered with Pfizer last September (2 PH1 drugs) and almost a year later they get bought out.  The way it seems to go 1) Good data. 2) partnership with big Pharma which leads up to 3) Buy Out.  Just IMHO 
Comment by HomerAndCompany on Aug 24, 2021 7:30am
My math says a 200% premium on 20.5 cents is the low 60 cent range. But maybe we  could see a 200% premium on a future higher SP? A $5 SP for example would give TLT a market cap of just over $1 billion, and a 200% premium on that would be just over $3 billion & $15/share. 
Comment by enriquesuave on Aug 24, 2021 7:36am
Trillium was trading at 35 cents in November 2019 and now is at $22 dollars Canadian. No worries for SP of TLT if we get the same outcome. 
Comment by gonefishing2022 on Aug 24, 2021 7:50am
I THINK YOU GUYS ARE A LITTLE IN DREAM WORLD BUT IT'S TERRIFIC WHEN THAT HAPPENS.
Comment by HomerAndCompany on Aug 24, 2021 8:02am
Yes!. But it's a dream ($15, $20+/share) that could come true! Obviously not the only possible outcome or the current SP would not be $0.205.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250